DCM
CELG

DAFNA Capital Management’s Celgene Corp CELG Stock Holding History

DAFNA Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-5,200
Closed -$562K – 94
2015
Q3 		$562K Buy
+5,200
New +$645K 0.56% 47

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

DAFNA Capital Management's CELG Position: Q4 2015 in Review

DAFNA Capital Management sold out of Celgene Corp (CELG) in Q4 2015, closing a stake of 5,200 shares — an estimated $562K sold.

DAFNA Capital Management first reported a position in CELG in Q3 2015 and held it in 1 quarter. The position peaked at $562K in Q3 2015. 1,246 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

  • DAFNA Capital Management reported no remaining Celgene Corp position as of Q4 2015 after selling out during the quarter.
  • DAFNA Capital Management sold 5,200 Celgene Corp shares in Q4 2015, an estimated $562K.
  • DAFNA Capital Management first reported a position in Celgene Corp in Q3 2015 and held it in 1 quarter.
  • DAFNA Capital Management's Celgene Corp position peaked at $562K in Q3 2015.
  • 1,246 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on DAFNA Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.